Alzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help experts monitor its development, progression, and ...

The landscape of dementia diagnostics is undergoing a paradigm shift with the emergence of liquid biopsy, blood-based biomarkers (BBMs), and blood-derived ...

Researchers from the National Institutes of Health have discovered a biomarker in the DNA of five different types of cancerous tumors, as well as evidence that the genetic signature may be present in ...

Diagnostic biomarkers are used to detect or confirm the presence of a disease or condition. They can help identify individuals with a particular disease or at high risk of developing the disease.

An expert in COPD delves into biomarkers indicative of type 2 inflammation and recommends diagnostic tests for assessing inflammation in COPD patients. Stay ahead of policy, cost, and value—subscribe ...

In this precision oncology era, where molecular profiling at the individual patient level becomes increasingly accessible and affordable, more and more clinical trials are now driven by biomarkers, ...

In oncology drug development, using biomarkers to select a study population more likely to benefit from a therapeutic effect is critical to increase the efficiency of a clinical trial in demonstrating ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...